These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23312256)

  • 1. Extensive postoperative ecchymosis in a patient taking dabigatran.
    Wagner CA; Oberoi N; Ahluwalia PK
    J Minim Invasive Gynecol; 2013; 20(1):127-30. PubMed ID: 23312256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential inaccuracy of point-of-care INR in dabigatran-treated patients.
    Baruch L; Sherman O
    Ann Pharmacother; 2011 Jul; 45(7-8):e40. PubMed ID: 21712509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Exfoliative esophagitis while taking dabigatran].
    Scheppach W; Meesmann M
    Dtsch Med Wochenschr; 2015 Apr; 140(7):515-8. PubMed ID: 25826037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dabigatran in prevention of stroke in atrial fibrillation: three years of clinical application].
    Zotova IV; Zateĭshchikov DA
    Kardiologiia; 2014; 54(2):79-85. PubMed ID: 24888206
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trial.
    Bytzer P; Connolly SJ; Yang S; Ezekowitz M; Formella S; Reilly PA; Aisenberg J
    Clin Gastroenterol Hepatol; 2013 Mar; 11(3):246-52.e1-5. PubMed ID: 23103906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
    Fieland D; Taylor M
    Ann Pharmacother; 2012 Jan; 46(1):e3. PubMed ID: 22202498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct thrombin inhibitors: a case indicating benefit from 'plasmapheresis' in toxicity: a call for establishing "guidelines" in overdose and to find an "antidote"!
    Kamboj J; Kottalgi M; Cirra VR; Shah N; Kamboj R
    Am J Ther; 2012 Nov; 19(6):e182-5. PubMed ID: 23154229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dabigatran as cause of severe gastrointestinal bleeding in a Jehovah's Witness patient].
    Holm J; Taskiran M
    Ugeskr Laeger; 2013 Feb; 175(6):334-6. PubMed ID: 23402236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advantages of NOAKs validated in clinical routine].
    Ameri AA
    MMW Fortschr Med; 2015 May; 157(9):70. PubMed ID: 26012835
    [No Abstract]   [Full Text] [Related]  

  • 10. Diffuse alveolar hemorrhage associated with dabigatran.
    Yokoi K; Isoda K; Kimura T; Adachi T
    Intern Med; 2012; 51(18):2667-8. PubMed ID: 22989848
    [No Abstract]   [Full Text] [Related]  

  • 11. Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention.
    Stöllberger C; Rakusan S; Wimpissinger FT; Finsterer J
    Thromb Haemost; 2012 Sep; 108(3):579-81. PubMed ID: 22739630
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronary embolization following electrical cardioversion in a patient treated with dabigatran.
    Gagliardi L; Guerbaai RA; Marlière S; Bouvaist H; Ennezat PV
    Int J Cardiol; 2014 Aug; 175(3):571-2. PubMed ID: 24861253
    [No Abstract]   [Full Text] [Related]  

  • 13. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S; Ansell J
    Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dabigatran: will it change clinical practice?
    Wartak SA; Bartholomew JR
    Cleve Clin J Med; 2011 Oct; 78(10):657-64. PubMed ID: 21968472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.
    Hohnloser SH; Oldgren J; Yang S; Wallentin L; Ezekowitz M; Reilly P; Eikelboom J; Brueckmann M; Yusuf S; Connolly SJ
    Circulation; 2012 Feb; 125(5):669-76. PubMed ID: 22215856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced exanthem following dabigatran.
    Whitehead H; Boyd JM; Blais DM; Hummel J
    Ann Pharmacother; 2011 Oct; 45(10):e53. PubMed ID: 21881034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma dabigatran activity one week after discontinuation despite normal renal function.
    Thachil J; Pike G; Keighley-Jones L; Nash MJ
    Am J Med; 2013 Aug; 126(8):e5-6. PubMed ID: 23800582
    [No Abstract]   [Full Text] [Related]  

  • 18. [Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery].
    Bachellerie B; Ruiz S; Conil JM; Crognier L; Seguin T; Georges B; Fourcade O
    Ann Fr Anesth Reanim; 2014 Jan; 33(1):44-6. PubMed ID: 24378048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal association of mechanical valve thrombosis with dabigatran: a report of two cases.
    Atar S; Wishniak A; Shturman A; Shtiwi S; Brezins M
    Chest; 2013 Jul; 144(1):327-328. PubMed ID: 23880682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation.
    Bendel SD; Bona R; Baker WL
    Adv Ther; 2011 Jun; 28(6):460-72. PubMed ID: 21533567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.